In a study that included children and young adults with relapsed or refractory cancer, incorporation of integrative clini¬cal genomic sequencing data into clinical management was feasible, re¬vealed potentially actionable findings in nearly half of the patients, and was associated with change in treatment and family genetics counseling for a small proportion of patients, according to a study in the Sept 1 issue of JAMA .
↧
Incorporating genomic sequencing, genetic counseling into pediatric cancer treatment shows benefit
↧